Association of left ventricular tissue heterogeneity and intramyocardial fat on computed tomography with ventricular arrhythmias in ischemic cardiomyopathy

[1]  R. Perea,et al.  Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention. , 2021, Heart rhythm.

[2]  Stefan L. Zimmerman,et al.  Personalized Digital-Heart Technology for Ventricular Tachycardia Ablation Targeting in Hearts With Infiltrating Adiposity , 2020, Circulation: Arrhythmia and Electrophysiology.

[3]  Katherine C. Wu,et al.  Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy , 2020, Journal of the American Heart Association.

[4]  K. Zeppenfeld,et al.  RV Tissue Heterogeneity on CT: A Novel Tool to Identify the VT Substrate in ARVC. , 2020, JACC. Clinical electrophysiology.

[5]  Katherine C. Wu,et al.  Substrate Spatial Complexity Analysis for the Prediction of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy , 2020, Circulation. Arrhythmia and electrophysiology.

[6]  M. Haissaguerre,et al.  Post–Myocardial Infarction Scar With Fat Deposition Shows Specific Electrophysiological Properties and Worse Outcome After Ventricular Tachycardia Ablation , 2019, Journal of the American Heart Association.

[7]  Katherine C. Wu.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications , 2017, Circulation. Cardiovascular imaging.

[8]  Colin Berry,et al.  Prevalence and Prognostic Significance of Lipomatous Metaplasia in Patients With Prior Myocardial Infarction. , 2015, JACC. Cardiovascular imaging.

[9]  Stefan L. Zimmerman,et al.  New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography--A pilot study. , 2015, Heart rhythm.

[10]  Yiyi Zhang,et al.  Protein Biomarkers Identify Patients Unlikely to Benefit From Primary Prevention Implantable Cardioverter Defibrillators: Findings From the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD) , 2014, Circulation. Arrhythmia and electrophysiology.

[11]  Katja Zeppenfeld,et al.  CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. , 2014, JACC. Cardiovascular imaging.

[12]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[13]  Hiroshi Ashikaga,et al.  The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. , 2011, Heart rhythm.

[14]  Kan Takeda,et al.  Adipose tissue detected by multislice computed tomography in patients after myocardial infarction. , 2009, JACC. Cardiovascular imaging.

[15]  Katja Zeppenfeld,et al.  Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.

[16]  N. Narula,et al.  Multidetector computed tomography shows intramyocardial fat deposition. , 2008, Journal of cardiovascular computed tomography.

[17]  Henry R. Halperin,et al.  Magnetic Resonance–Based Anatomical Analysis of Scar-Related Ventricular Tachycardia: Implications for Catheter Ablation , 2007, Circulation research.

[18]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[19]  M. Fishbein,et al.  Adipose tissue in myocardial infarction. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.